(NASDAQ: IRIX) Iridex's forecast annual revenue growth rate of 4.77% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.83%.
Iridex's revenue in 2026 is $52,675,000.On average, 3 Wall Street analysts forecast IRIX's revenue for 2026 to be $939,653,415, with the lowest IRIX revenue forecast at $902,788,651, and the highest IRIX revenue forecast at $967,276,027. On average, 3 Wall Street analysts forecast IRIX's revenue for 2027 to be $1,002,254,285, with the lowest IRIX revenue forecast at $962,966,484, and the highest IRIX revenue forecast at $1,031,746,096.
In 2028, IRIX is forecast to generate $1,060,078,311 in revenue, with the lowest revenue forecast at $1,018,505,934 and the highest revenue forecast at $1,091,248,940.